President Uhuru Kenyatta And The President Of South Africa, His Excellency President Cyril Ramaphosa Hold Bilateral Talks.

Uhuru in SA
image: nation
Uhuru in SA
image: nation

President Uhuru Kenyatta in bilateral  meetings with President Cyril Ramaphosa at the union buildings in Pretoria.

During a press briefing  Ambassador Catherine Muigai Mwangi said the highlight of the visit is the  bilateral meeting at the Union Buildings where the two heads of state will sign  some memoranda of understanding (MOUs)  to anchor the engagement of the two countries in a number of areas.

“It is indeed an exciting visit for both Kenya and South Africa. We have an excellent programme for His Excellency, the President.”

Of course the highlight of the visit will be his meeting with the President of South Africa, His Excellency President Ramaphosa, at a bilateral meeting which will be attended by both principals and their delegations,Amb Mwangi said.

 

Amb Mwangi, yesterday,  pointed out that MOUs on migration matters, tourism and diplomatic consultations are some of the key diplomatic instruments  expected to be signed at the Tuesday high-level bilateral meeting.

The ambassador said the agreement seeks to boost the tourism sectors in both countries and create opportunities for investment as well as providing a knowledge exchange platform.

Because tourism is such an important sector for Kenya, it is essential that we look at every opportunity to increase tourist numbers and improve on our products,she said.

President Kenyatta and his host will also preside over a joint Kenya- South Africa business forum to further explore news areas of economic, trade and investment cooperation.

This is a big opportunity because trade and trade-related matters as well as investment are of great importance to both countries. This is an area that we are looking forward to strengthening, deepening and indeed cementing Amb Mwangi said.

President Kenyatta is also expected to visit the Aspen Pharmacare, the South African-based subsidiary of Aspen, a global multinational pharmaceutical company that manufactures and distributes the Johnson and Johnson Covid-19 vaccines.

The strategic partnership between the two states is bolstered by common values and principles with both nations showing commitment to democracy, good governance and respect for human rights including efforts towards full realization of gender equality.

Leave a Reply